TCC-CASEMIX is a sophisticated digital health technology platform that provides total traceabilty of medical devices used in operating rooms. It is primarily aimed at medical device companies seeking independent performance data enabling them to plug the gaps in their performance data and also to differentiate their products in the international medical devices marketplace. We specialise in all phases of medical device data acquisition through our TCC-Real World Evidence Centre brand. We analyse products in-use relative to the patient complexities presented in each operation. Our algorithms create whole new insights, placing medical device performance in the context of their impact on specific areas of patient health. This is a unique capability. As one major manufacturer described : "We understand too little about the performance of our devices in-use, meaning that we are unable to grow market share, because we lack the evidence to support our value-proposition." Another recently wrote: “TCC-CASEMIX has conceived, planned, and implemented a trial in a very effective timescale like nothing that we have ever previously experienced. Their attention to detail, meticulous planning and communication has been excellent. As a start-up medical device company this has been invaluable to my business. What makes their service so unique is their ability to facilitate a product sale, provide a key opinion leader for the principal investigator role, a fast, efficient ethical consent process, and patient enrolment in a complete package of services – it is quite exemplary.” TCC-CASEMIX provides that evidence. It is published into a unique Open Registry Infrastructure (ORI) - an 'Internet of Medical Devices'. It is through the ORI and the Data Access Portal that manufacturers are able to find out where and how their devices have been performing anywhere in the world where the TCC-CASEMIX platform has been deployed.